NPS PHARMACEUTICALS INC. / SHIRE PLC / Acquisition / Public / £3332m

Financials

Transaction Value-

Consideration TypeCash

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

Nps Pharmaceuticals Inc.

Shire

Sources

Tags

Biotechnology

rare-diseases company

United States

Public

Acquisition

Completed

Friendly

Single Bidder

Synopsis

Goldman Sachs

Skadden Arps Slate Meagher & Flom

Citigroup

Lazard

Slaughter & May

Davis Polk & Wardwell

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.